LINDSEY THOMAS: Open Payments
NPI 1326575663 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,149 in 40 payments from 20 companies in 2025. Trend: 2023 $327 · 2024 $689 · 2025 $1,149
Food & beverage: $864Education: $285
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $211 |
| Incyte Corporation | 2 | $140 |
| Regeneron Healthcare Solutions, Inc. | 4 | $132 |
| Janssen Biotech, Inc. | 2 | $121 |
| ABBVIE INC. | 5 | $113 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| LEO Pharma Inc. | 4 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $39 |
| DePuy Synthes Sales Inc. | 1 | $29 |
Products named: Sotyktu, DUPIXENT, Opzelura, TREMFYA, RINVOQ, SKYRIZI, ANZUPGO, LifeVest.
Industry payments across OK — which companies pay providers there.
